Ianalumab lengthens time patients can maintain safe platelet levels
A Phase 3 clinical trial testing ianalumab (VAY736) in combination with Promacta (eltrombopag) in people with primary immune thrombocytopenia (ITP) has met its main…
Immune thrombocytopenia
AI predicts how kids with ITP will respond to rituximab infusion
Artificial intelligence (AI) can accurately predict a response to the second-line therapy rituximab in children and adolescents with immune thrombocytopenia (ITP), according to a…
Old pennies, raw liver, and the taste of blood being transfused
The tastes of metal and a bloody organ swirled together in the back of my throat, similar to the smell of old pennies and raw…
Boosting platelet counts in ITP is aim of efgartigimod study
A Phase 3 trial testing efgartigimod administered into a vein in adults with primary immune thrombocytopenia (ITP) is still enrolling participants and its top-line…
Doptelet, Doptelet Sprinkle for pediatric ITP win FDA approval
Sobi’s Doptelet (avatrombopag), which is available as a tablet and an oral granule called Doptelet Sprinkle, is now approved in the U.S. for children…
Gut bacteria types may influence ITP progression in children: Study
Children and adolescents newly diagnosed with immune thrombocytopenia (ITP) show clear differences in gut microbiota — the community of bacteria and other microbes living…
Doptelet found safe, effective in previously treated children with ITP
Doptelet (avatrombopag) was safe and effective in children with immune thrombocytopenia (ITP) who had an insufficient response to previous treatments, according to recently…
Hetrombopag is safe, effective for ITP in real-world settings: Study
Hetrombopag appears to be a safe and effective option in real-world settings for immune thrombocytopenia (ITP), with better outcomes linked with a higher starting…
